Navigation Links
CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
Date:8/14/2008

PALO ALTO, Calif., Aug. 14 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX) announced today that it has received approval from the European Medicines Agency (EMEA) for the brand name Ranexa(R) (ranolazine).

On July 10, 2008, the Company announced that the EMEA had granted marketing authorization for ranolazine in all 27 European Union (EU) member states under the brand name Latixa.

"Securing approval for the Ranexa brand name in Europe provides important brand synergy in the world's two largest cardiovascular markets, the U.S. and the EU," said Louis G. Lange, M.D., Ph.D., chairman and chief executive officer of CV Therapeutics.

Ranexa is approved for use in Europe as an add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line antianginal therapies. The product is approved for use in 375 mg, 500 mg and 750 mg doses, administered twice daily.

About CV Therapeutics

CV Therapeutics, Inc., headquartered in Palo Alto, California, is a biopharmaceutical company primarily focused on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases. CV Therapeutics Ltd. is the company's European subsidiary based in the United Kingdom.

CV Therapeutics' approved products in the United States include Ranexa(R) (ranolazine extended-release tablets), indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs, and Lexiscan(TM) (regadenoson) injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging in patients unabl
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...d LOS ANGELES, Nov. 30 /PRNewswire-Asia-FirstCall/...tin Board: CYXN; ,China Yongxin,Pharmaceuticals, o...tor and,retailer of pharmaceuticals in Northeaster...ion for distribution of medicines on the Essential...ntly formalized the nation,s Essential Drug,List w...
(Date:11/30/2009)...r in providing smart and efficient software to the...®, evolutionizing work-from-home histopatholog...; software used by 8 of the Top 10 Pharmaceutical ...lide’ basis. , Moun...as announced another evolution in the histopatholo...
(Date:11/30/2009)... /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX ...dical-device research and,development outsourcing ...ates,announced that it had been selected to the D... fifth consecutive year. The list recognizes the 5... media, and telecommunications,industries based on...
(Date:11/29/2009)...n . , The concept of confinement is one of t...s example is that of quarks which bind together to...rom Helmholtz-Zentrum Berlin together with an inte...time an experimental realization and a proof of co...r system. , The concept of confinement states th...
Breaking Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Spinons -- confined like quarks 2
...Drug,Delivery: Emerging Modes, Novel Science and P...for October 29-30, 2007, at the Flamingo in Las,Ve...in controlled release,technologies, nanobiomedicin...g delivery, tumor targeting and other novel applic...ther systemic drug absorption,platforms. The prog...
...e "Company") (Nasdaq: VRML ) announced today that...Stock Market ("Nasdaq") that the Company has,regai...)(3) as a result of,achieving a market value of li...35 million or more for a period of 10 consecutive ...st 17, 2007 that the Company was not in,compliance...
...SPeRATE Hypertension Treatment Device ..., Sept. 17 InterCure, Ltd. (TASE:,INCR), today an...nt device,clinically-proven in 10 peer-reviewed st...launch into retail distribution in the United King...stributor of healthcare,diagnostics to the indepen...
Other Biology Technology:Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIG's Plenary Panel in Vegas 2Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIG's Plenary Panel in Vegas 3Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq 2InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom 2InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom 3InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom 4
(Date:11/25/2009)...ors recently received funding from the National Sc...cial to understanding the environment. The three g...ssistant professor in the Department of Biological...ate research projects. , His first project, titl...unctions from the Leaf to the Landscape," will exa...
(Date:11/24/2009)... may help gut bacteria bind to the gastrointestina...oducers to identify strains that are likely to be ...interact with cells lining the gut to have a benef...e gut they are more likely to stick around long en...ge from the Institute of Food Research. IFR is an...
(Date:11/24/2009)...rets of the earth,s history locked in its icy dept... information on the environments that have been se...ow, a team of researchers from nine institutions ... million dollars by the National Science Foundatio...ly. These scientists will drill through the West A...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2GENova Biotherapeutics signs collaboration agreement with Prime BioResearch 57276 1GENova Biotherapeutics signs collaboration agreement with Prime BioResearch 57276 2GENova Biotherapeutics signs collaboration agreement with Prime BioResearch 57276 3FDA Approves Vaccines for 2009 H1N1 Influenza Virus 57274 1FDA Approves Vaccines for 2009 H1N1 Influenza Virus 57274 2FDA Approves Vaccines for 2009 H1N1 Influenza Virus 57274 3Diabetes Medications Dont Lower Inflammation 57271 1Diabetes Medications Dont Lower Inflammation 57271 2Diabetes Medications Dont Lower Inflammation 57271 3
...sociation for Cancer Research extends its sincere ...nomination to lead the Food and Drug Administratio...see the advancement of cutting-edge products and t...vention of cancer. Her leadership will bring new p...devising regulatory pathways for biomarker approva...
...roviral therapy) has emerged as an extremely effec...undetectable; however, HAART can never truly eradi...in cells. But, a chemical called suberoylanilide h...emia drug, has now been shown to ,turn on, latent ... the hidden virus that HAART misses. , Matija Pe...
...ygen atoms dancing on a metal oxide slab, glowing ...ts better understand how water splits into oxygen ...visualized a chemical reaction that had previously... understanding of the chemistry needed to generate... water. , The scientists made the discovery while...
Other Biology News:Dancing 'adatoms' help chemists understand how water molecules split 2Dancing 'adatoms' help chemists understand how water molecules split 3
PCR Optimization Kit; Kit for optimization of PCR from Roche Applied Science
...cans MiniPrep series of robotic workstations is de...iniPrep is the ideal automation platform for routi...e laboratory procedures, improving throughput, pro...ini for MiniPrep software allows you to control th...
Mouse Anti-Human CDC2L5 Monoclonal Antibody, Unconjugated, Clone 1B3-1B11 from Novus Biologicals
FluoroGuard Antifade Reagent from Bio-Rad
Biology Products: